Centers for Medicare & Medicaid Services
US administrator of the CLIA program (42 CFR Part 493) — the certification regime every US laboratory testing human specimens operates under, separate from FDA's regulation of the tests themselves.
What this page does not claim
SPEQ curates and cross-references these bodies. It is not affiliated with, accredited by, or endorsed by any of them, and a count of decoded standards is a measure of SPEQ’s coverage, not of a body’s importance.
WHAT CMS COVERS
The Centers for Medicare & Medicaid Services is the US agency that administers the Clinical Laboratory Improvement Amendments of 1988 (CLIA, 42 U.S.C. 263a) — the certification regime for every US laboratory testing human specimens for health assessment or the diagnosis, prevention, or treatment of disease. Its regulatory instrument is 42 CFR Part 493, which ties a laboratory's certificate to the complexity of its testing and sets the proficiency-testing, quality-system, personnel, and inspection requirements behind it. CMS is best known as the payer agency for Medicare and Medicaid; in the GxP world it appears in exactly one role — the regulator of clinical-laboratory operations.
WHAT CMS PUBLISHES
- 0142 CFR Part 493 — the CLIA regulations (certificates, proficiency testing, quality systems, personnel, inspections)
- 02The CLIA State Operations Manual and interpretive guidelines surveyors work from
- 03CLIA certificate and laboratory-registry data, publicly searchable
- 04CLIA-related rulemakings and guidance issued with CDC and FDA under the tri-agency arrangement
HOW ITS REQUIREMENTS BITE
Certification plus inspection. A laboratory cannot lawfully test human specimens without a CLIA certificate matched to its test complexity — waiver, provider-performed microscopy, compliance, or accreditation — and certificates of compliance are surveyed by CMS and its state agents, while certificates of accreditation are surveyed by CMS-approved accreditation organisations whose requirements must meet or exceed CLIA's. Enforcement runs from directed plans of correction through civil money penalties to certificate revocation, with proficiency-testing referral violations carrying the severest sanctions. The division of labour with FDA is structural: CMS certifies the laboratory's operation; FDA regulates the tests and instruments and categorises their complexity.
What practitioners get wrong
- CMS regulates the lab, not the test — device clearance, complexity categorisation, and labelling questions belong to FDA, and conflating the two agencies misroutes compliance questions.
- The certificate type bounds what a laboratory may perform: trial assays placed in a waived-certificate site are being run outside the certificate, whatever the site's clinical quality.
- Proficiency-testing referral — sending a PT sample to another laboratory, even for well-meant confirmation — is prohibited and sanctioned severely; it is the CLIA violation that ends laboratories.
- Research testing that reports no patient-specific results sits outside CLIA, but the moment a result informs care of an identified person, certification is required.
What an inspection under this authority actually probes
WHERE IT SITS INTERNATIONALLY
CLIA operates as a tri-agency system — CMS administering, the CDC providing scientific support, FDA categorising test complexity — and its international counterpart is ISO 15189 accreditation for medical laboratories: CMS-approved accreditation organisations bridge the two by mapping their programmes onto CLIA requirements. For globally distributed clinical trials, WHO GCLP guidance and national licensing govern non-US laboratories while CLIA governs testing of US specimens.
CMS STANDARDS SPEQ DECODES · 1
DISCIPLINES IN CMS’S REMIT
CMS: frequently asked questions
Reference answers on Centers for Medicare & Medicaid Services’s mandate, what it publishes, and how its requirements acquire force.
What is CLIA?
The Clinical Laboratory Improvement Amendments of 1988 — the US law under which CMS certifies every laboratory testing human specimens for clinical purposes, implemented through 42 CFR Part 493's certificate, proficiency-testing, quality-system, personnel, and inspection requirements.
How is CMS's role different from FDA's in laboratory testing?
CMS certifies and inspects the laboratory's operation under CLIA. FDA regulates the tests themselves — clearance or approval of assays and instruments, and categorisation of their complexity. A quality question about how a lab operates is CLIA/CMS; a question about the test product is FDA.
What CLIA certificate types exist?
Certificate of waiver (waived tests), provider-performed microscopy, certificate of registration (while awaiting survey), certificate of compliance (surveyed by CMS/state agencies), and certificate of accreditation (surveyed by a CMS-approved accreditation organisation). The type must match the complexity of testing performed.